Depletion and bioavailability of 14C-oxibendazole residues in swine tissues

Veterinary Parasitology

Volumn 64, Issue 1-2, 1996, Pages 83-93

  Gottschall, David W ^a   Wang, Richard ^a  

^a PFIZER INC   (United States)

Author keywords

Bioavailability; Depletion; Oxibendazole; Swine

Indexed keywords

CARBON 14; OXIBENDAZOLE; ANTHELMINTIC AGENT; BENZIMIDAZOLE DERIVATIVE; CARBON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG LIVER LEVEL; DRUG METABOLISM; DRUG SOLUBILITY; FOOD SAFETY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARASITE CONTROL; RAT; SWINE; ANIMAL; ARTICLE; BIOAVAILABILITY; FOOD CONTAMINATION; HUMAN; INTESTINE ABSORPTION; LIVER; MEAT; METABOLISM; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANIMALIA; SUS SCROFA;

ADMINISTRATION, ORAL; ANIMALS; ANTHELMINTICS; BENZIMIDAZOLES; BIOLOGICAL AVAILABILITY; CARBON RADIOISOTOPES; FOOD CONTAMINATION; HUMANS; INTESTINAL ABSORPTION; LIVER; MALE; MEAT; RATS; RATS, SPRAGUE-DAWLEY; SWINE; TISSUE DISTRIBUTION;

EID: 0030201353     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-4017(96)00963-6     Document Type: Conference Paper

References (12)

1. Chiu, S.L. and Lu, A.Y.H., 1989. Metabolism and tissue residues. In: W.C. Campbell (Editor), Ivermectin and Abamectin. Springer-Verlag, New York, pp. 131-143.
2. Chiu, S.L., Sestokas, E., Taub, R., Buhs, R.P., Green, M., Sestokas, R., Vandenheuval, W.J.A., Arison, B.H. and Jacob, T.A., 1986. Metabolic disposition of ivermectin in tissues of cattle, sheep, and rats. Drug Metab. Dispos. 14(5): 590-600.
3. CVM, 1994. Center for Veterinary Medicine Guidelines, No. 3, July 1994. General Principles for Evaluating the Safety of Compounds Used in Food-Producing Animals (Guidelines I-VII). Food and Drug Administration (SOM).
4. Gallo-Torres, H.E., 1977. Methodology for the determination of bioavailability of labeled residues. J. Toxicol. Environ. Health, 2: 827-845.
5. 14C-furazolidone residues in swine tissues. J. Agric. Food Chem., 43(9): 2520-2525.
6. Gottschall, D.W., Gombatz, C. and Wang R., 1987a. Analysis of tissue residues and comparative metabolism of virginiamycin in rats, turkeys and cattle. J. Agric. Food Chem., 35: 900-904.
7. Gottschall, D.W., Gombatz, C. and Wang, R., 1987b. Investigation into the nature of virginiamycin residues in rat liver. Drug Metab. Rev., 18(2-3): 215-233.
8. MacDonald, A., Laurencot, H. and Elsom, L., 1990. The use of bioavailability studies in the evaluation of tissue residues. In: N. Haagsma, A. Ruiter and P.B. Czedik-Eysenberg (Editors), Residues of Veterinary Drugs in Food, Proc. Euro Residue Conference, Noordwijkerhout, The Netherlands, 1990, pp. 259-263.
9. Vilim, A., 1990. Definition of bound residues. Drug Metab. Rev., 22(6-8) 591-593.
10. Weber, N.E., 1980. Persistent residues: interface with regulatory decisions, J. Toxicol. Environ. Health, 3: 35-43.
11. Weber, N.E., 1992. Use of xenobiotics in food-producing animals in the United States: regulatory aspects. In: D.H. Hutson, D.R. Hawkins, G.D. Paulson and C.B. Struble (Editors), Xenobiotics and Food-Producing Animals: Metabolism and Residues. ACS Symposium Series No. 503. American Chemical Society, Washington, DC, pp. 17-25.
12. World Health Organization, 1989. Technical Report Series No. 788. Evaluation of Certain Veterinary Drug Residues in Food. 34th Report of the Joint FAO-WHO Expert Committee on Food Additives. World Health Organization, Geneva, pp. 14-20.